Cargando…
GeVaDSs – decision support system for novel Genetic Vaccine development process
BACKGROUND: The lack of a uniform way for qualitative and quantitative evaluation of vaccine candidates under development led us to set up a standardized scheme for vaccine efficacy and safety evaluation. We developed and implemented molecular and immunology methods, and designed support tools for i...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531312/ https://www.ncbi.nlm.nih.gov/pubmed/22574945 http://dx.doi.org/10.1186/1471-2105-13-91 |
_version_ | 1782254153705193472 |
---|---|
author | Blazewicz, Jacek Borowski, Marcin Chaara, Wahiba Kedziora, Pawel Klatzmann, David Lukasiak, Piotr Six, Adrien Wojciechowski, Pawel |
author_facet | Blazewicz, Jacek Borowski, Marcin Chaara, Wahiba Kedziora, Pawel Klatzmann, David Lukasiak, Piotr Six, Adrien Wojciechowski, Pawel |
author_sort | Blazewicz, Jacek |
collection | PubMed |
description | BACKGROUND: The lack of a uniform way for qualitative and quantitative evaluation of vaccine candidates under development led us to set up a standardized scheme for vaccine efficacy and safety evaluation. We developed and implemented molecular and immunology methods, and designed support tools for immunization data storage and analyses. Such collection can create a unique opportunity for immunologists to analyse data delivered from their laboratories. RESULTS: We designed and implemented GeVaDSs (Genetic Vaccine Decision Support system) an interactive system for efficient storage, integration, retrieval and representation of data. Moreover, GeVaDSs allows for relevant association and interpretation of data, and thus for knowledge-based generation of testable hypotheses of vaccine responses. CONCLUSIONS: GeVaDSs has been tested by several laboratories in Europe, and proved its usefulness in vaccine analysis. Case study of its application is presented in the additional files. The system is available at: http://gevads.cs.put.poznan.pl/preview/(login: viewer, password: password). |
format | Online Article Text |
id | pubmed-3531312 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35313122013-02-12 GeVaDSs – decision support system for novel Genetic Vaccine development process Blazewicz, Jacek Borowski, Marcin Chaara, Wahiba Kedziora, Pawel Klatzmann, David Lukasiak, Piotr Six, Adrien Wojciechowski, Pawel BMC Bioinformatics Software BACKGROUND: The lack of a uniform way for qualitative and quantitative evaluation of vaccine candidates under development led us to set up a standardized scheme for vaccine efficacy and safety evaluation. We developed and implemented molecular and immunology methods, and designed support tools for immunization data storage and analyses. Such collection can create a unique opportunity for immunologists to analyse data delivered from their laboratories. RESULTS: We designed and implemented GeVaDSs (Genetic Vaccine Decision Support system) an interactive system for efficient storage, integration, retrieval and representation of data. Moreover, GeVaDSs allows for relevant association and interpretation of data, and thus for knowledge-based generation of testable hypotheses of vaccine responses. CONCLUSIONS: GeVaDSs has been tested by several laboratories in Europe, and proved its usefulness in vaccine analysis. Case study of its application is presented in the additional files. The system is available at: http://gevads.cs.put.poznan.pl/preview/(login: viewer, password: password). BioMed Central 2012-05-10 /pmc/articles/PMC3531312/ /pubmed/22574945 http://dx.doi.org/10.1186/1471-2105-13-91 Text en Copyright ©2012 Blazewicz et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Software Blazewicz, Jacek Borowski, Marcin Chaara, Wahiba Kedziora, Pawel Klatzmann, David Lukasiak, Piotr Six, Adrien Wojciechowski, Pawel GeVaDSs – decision support system for novel Genetic Vaccine development process |
title | GeVaDSs – decision support system for novel Genetic Vaccine development process |
title_full | GeVaDSs – decision support system for novel Genetic Vaccine development process |
title_fullStr | GeVaDSs – decision support system for novel Genetic Vaccine development process |
title_full_unstemmed | GeVaDSs – decision support system for novel Genetic Vaccine development process |
title_short | GeVaDSs – decision support system for novel Genetic Vaccine development process |
title_sort | gevadss – decision support system for novel genetic vaccine development process |
topic | Software |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531312/ https://www.ncbi.nlm.nih.gov/pubmed/22574945 http://dx.doi.org/10.1186/1471-2105-13-91 |
work_keys_str_mv | AT blazewiczjacek gevadssdecisionsupportsystemfornovelgeneticvaccinedevelopmentprocess AT borowskimarcin gevadssdecisionsupportsystemfornovelgeneticvaccinedevelopmentprocess AT chaarawahiba gevadssdecisionsupportsystemfornovelgeneticvaccinedevelopmentprocess AT kedziorapawel gevadssdecisionsupportsystemfornovelgeneticvaccinedevelopmentprocess AT klatzmanndavid gevadssdecisionsupportsystemfornovelgeneticvaccinedevelopmentprocess AT lukasiakpiotr gevadssdecisionsupportsystemfornovelgeneticvaccinedevelopmentprocess AT sixadrien gevadssdecisionsupportsystemfornovelgeneticvaccinedevelopmentprocess AT wojciechowskipawel gevadssdecisionsupportsystemfornovelgeneticvaccinedevelopmentprocess |